SARS-CoV-2 Archives | Be Korea-savvy
Coronavirus Causes Blood Vessel Inflammation, Immune Inhibition

Coronavirus Causes Blood Vessel Inflammation, Immune Inhibition

SEOUL, Aug. 5 (Korea Bizwire) — The novel coronavirus causes blood vessel inflammation and inhibits immune response, tests conducted on primates indicated Wednesday. The infection model research by state-run Korea Research Institute of Bioscience and Biotechnology (KRIBB) showed animals exposed to the SARS-CoV-2 experienced rapid multiplying of the virus in the throat and lungs two [...]

Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China

Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China

SHANGHAI, China, July 12 (Korea Bizwire) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today the completion of study subjects enrollment in Phase I trial of SARS-CoV-2 neutralizing monoclonal antibody injection (Product Code: JS016), developed jointly with Institute of Microbiology, Chinese Academy [...]

Cell Publication Elucidates How SARS-CoV-2 Dramatically Rewires Important Cell Programming; Identifies Existing Therapeutics That May Fight COVID-19

Cell Publication Elucidates How SARS-CoV-2 Dramatically Rewires Important Cell Programming; Identifies Existing Therapeutics That May Fight COVID-19

SAN FRANCISCO, June 28 (Korea Bizwire) — Pioneering a new paradigm in drug discovery by leveraging biological understanding of how a virus interacts with its host, an international team of researchers conducted a global analysis of proteins in human cells to determine mechanisms by which SARS-CoV-2 shifts cellular activity in infected cells. During the study, [...]